Login
From:
Synox | Website
(Uncensored)
subscribe
SynOx Therapeutics to present two posters at CTOS 2021 virtual Annual Meeting
https://synoxtherapeutics.com/synox-therapeutics-to-present-two-posters-at-ctos-2021-virtual-annual-meeting/
links
backlinks
Axel Mescheder, CMO, to present an update on phase III, registrational trial of emactuzumab for patients suffering with TGCT (TANGENT) … Continue reading "SynOx Therapeutics to present two posters at CTOS 2021 virtual Annual Meeting"
Roast topics
Find topics
Find it!
